Renaissance Capital logo

Hong Kong Pharma Digital Technology Priced, Nasdaq: HKPD

Provides cross-border supply chain and distribution services for OTC drugs in China.

Industry: Health Care

Latest Trade: $1.77 0.00 (0.0%)

First Day Return: -29.5%

Return from IPO: -55.7%

Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division. Based in Hong Kong, Joint Cross Border has established itself as a leading provider of third-party supply chain services in Mainland China’s OTC pharmaceutical cross-border e-commerce market. According to the F&S Report, we ranked first in this sector by revenue in 2022. Through our engagement with OTC pharmaceutical suppliers, logistics companies, and merchants who operate stores on Chinese e-commerce platforms, Joint Cross Border offers a convenient one-stop solution for Mainland Chinese customers who wish to access OTC pharmaceutical products outside Mainland China. Joint Cross Border’s offering includes a comprehensive array of services, such as pre-consultation, product information review, procuring overseas OTC pharmaceutical products, enlisting OTC pharmaceutical products to the Hong Kong Department of Health, obtaining import and export permits and clearances, storing products at warehouses, packaging, and arranging for logistics and end-to-end delivery services for consumers.
IPO Data
IPO Date 01/14/2025
Offer Price $4.00
Price Range $4.00 - $6.00
Offer Shares (mm) 1.4
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Bancroft Capital
Eddid Securities and Futures
Company Data
Headquarters Hong Kong, China
Founded 2016
Employees at IPO 19
Website www.9zt.hk

Hong Kong Pharma Digital Technology (HKPD) Performance

Created with Highcharts 10.3.2Chart context menuHKPD vs. IPO Index (IPOUSA)14. Jan16. Jan20. Jan22. Jan26. Jan28. Jan30. Jan3. Feb5. Feb9. Feb11. Feb13. Feb17. Feb19. Feb21. Feb0%-75%-50%-25%+ 25%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexHKPDOur ETF tracks the IPO Index